bitolterol mesylate, Tornalate

Pharmacy Author:
Medical and Pharmacy Editor:
Medical and Pharmacy Editor:

GENERIC NAME: bitolterol mesylate

BRAND NAME: (Tornalate: This brand no longer is available in the U.S. and there are no generic versions.)

DRUG CLASS AND MECHANISM: Bitolterol is a bronchodilator used in the treatment of asthma. It is similar to albuterol (Ventolin). Asthma is a disorder of breathing in which there is narrowing of the airways that carry air to the lungs including the bronchi. This narrowing is caused by muscle spasm and inflammation within the airways. Bitolterol relaxes the smooth muscles surrounding these airways, increasing the diameter and thus easing the flow of air through the airways. Bitolterol probably does not affect inflammation in the lung either with asthma or other inflammatory lung disorders such as bronchitis. Nevertheless, if spasm of the airways occurs because of bronchitis, bitolterol may be useful therapy for the asthmatic component of the illness. Bitolterol is unique in that it is a "prodrug;" It must first be converted by the body into its active form. Bitolterol has a rapid onset of action (2-5 minutes), and its effects may last up to 6-8 hours. The FDA approved bitolterol in December 1984.

PRESCRIPTION: Yes

GENERIC AVAILABLE: No

PREPARATIONS: Inhaler: 0.37 mg/Inhalation; Solution for Inhalation: 0.2%

STORAGE: Bitolterol should be stored at room temperature, 15 C to 30 C (59 F to 86 F).

PRESCRIBED FOR: Bitolterol is used for the relief of bronchospasm due to asthma and other respiratory illnesses.

DOSING: The recommended adult dose for treating asthma is 2 inhalations every 8 hours. Maximum dose is 2 inhalations every 4 hours or 3 inhalations every 6 hours. This drug was not approved for use in children under 12 years old.

DRUG INTERACTIONS: Tricyclic antidepressants (for example, amitriptyline [Elavil, Endep]), monoamine oxidase inhibitors (for example, tranylcypromine) should not be combined with bitolterol because of their additive effects on the vascular system (increased blood pressure, heart rate, etc.). A period of two weeks should elapse between treatment with bitolterol and tricyclic antidepressants or monoamine oxidase inhibitors.

Use of bitolterol with other stimulant medications is discouraged because of their combined effects on heart rate, blood pressure, and the potential for causing chest pain in patients with underlying coronary heart disease.

Beta-blockers, for example, propranolol (Inderal, Inderal LA), block the effect of bitolterol and may induce bronchospasm in asthmatics. Bitolterol may cause hypokalemia (low potassium). Therefore, combining bitolterol with loop diuretics, for example, furosemide (Lasix), which lowers potassium levels in the blood, may increase the likelihood of hypokalemia.

PREGNANCY: There are no adequate studies in pregnant women.

NURSING MOTHERS: It's not known if bitolterol is excreted in breast milk.

SIDE EFFECTS: Side effects of bitolterol include nervousness, tremor, headache, palpitations, fast heart rate, elevated blood pressure, nausea, dizziness, and heartburn. Throat irritation and nosebleeds can also occur. Allergic reactions may occur rarely and may manifest as rash, hives, swelling, anaphylaxis, or shock. Worsening of diabetes and lowering of potassium have also been reported. In rare patients, inhaled bitolterol can paradoxically precipitate life-threatening bronchospasm.

Reference: FDA Prescribing Information


Medically Reviewed by a Doctor on 8/27/2014



Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index